“…Thus, we could expect that the difference in their melting points would be due to some structural peculiarities, involving either their space groups if the two SOaz are unsolvated in the crystal or an eventual insertion of solvent in the unit cell (clathrate structure): this was indeed observed previously for another anticancer inorganic ring, the hexaaziridinylcyclotri(phosphazene) N3P3az 6, which may either crystallize unsolvated (Cameron et al, 1981), or give clathrates with carbon tetrachloride (N3P3az6.3CCI4) (Galy, Enjalbert & Labarre, 1980) and with benzene (2N3P3az 6.C6H 6) (Cameron, Labarre & Graffeuil, 1982).…”